Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$537K Hold
9,885
0.14% 92
2015
Q1
$542K Hold
9,885
0.13% 94
2014
Q4
$536K Buy
9,885
+112
+1% +$6.24K 0.13% 92
2014
Q3
$553K Hold
9,773
0.14% 89
2014
Q2
$539K Hold
9,773
0.13% 95
2014
Q1
$529K Sell
9,773
-7,647
-44% -$396K 0.12% 91
2013
Q4
$832K Sell
17,420
-63
-0.4% -$2.88K 0.19% 80
2013
Q3
$794K Buy
17,483
+63
+0.4% +$2.88K 0.2% 78
2013
Q2
$772K Buy
+17,420
New +$778K 0.2% 74

Other funds holding MRK

Highmount Capital's MRK Position: Q2 2015 in Review

Highmount Capital held its Merck (MRK) position steady in Q2 2015 at 9,885 shares worth $537K. The position accounts for 0.14% of the portfolio, ranked #92.

Highmount Capital first reported a position in MRK in Q2 2013 and has held it in 9 quarters since. The position peaked at $832K in Q4 2013. 1,726 funds tracked by Wall St. Rank hold MRK as of Q2 2015.

  • Highmount Capital held 9,885 shares of Merck worth $537K as of Q2 2015.
  • Highmount Capital left its Merck share count unchanged in Q2 2015.
  • Merck made up 0.14% of Highmount Capital's portfolio in Q2 2015, its #92 holding.
  • Highmount Capital first reported a position in Merck in Q2 2013 and has held it in 9 quarters since.
  • Highmount Capital's Merck position peaked at $832K in Q4 2013.
  • 1,726 funds tracked by Wall St. Rank held Merck as of Q2 2015.

Based on Highmount Capital's 13F filing for Q2 2015, filed 14 Aug 2015.